Individuals with a family history of colorectal cancer (CRC) may benefit from early screening
with colonoscopy or immunologic fecal occult blood testing (iFOBT). We systematically …

Background Colorectal cancer (CRC) is the second most common malignant disease and
the second most common cause of cancer death in Germany. Official CRC screening starts …

Background Screening colonoscopy can lower the incidence of colorectal cancer (CRC), yet
participation rates are low even in groups at high risk. The goal of this study was to double …

Objective Because colorectal cancer (CRC) has a long natural history, estimating the
effectiveness of CRC screening programmes requires long-term follow-up. As an alternative …

Background Persons with a positive family history of colorectal cancer (CRC) are more likely
than others to develop CRC and are also younger at the onset of the disease. Nonetheless …

Background Clear evidence on the benefit-harm balance and cost effectiveness of
population-based screening for colorectal cancer (CRC) is missing. We aim to systematically …

The lifetime risk of developing colorectal cancer (CRC) for any individual in Europe is
approximately 5%. Annually, approximately 400000 individuals are being diagnosed with …

Clinical practice guidelines recommend initiating routine screening for colorectal cancer
(CRC) in people at average disease risk starting at age 50 and repeated at varying intervals …

Aim Endoscopy based screening programmes for colorectal cancer (CRC) are being
implemented in an increasing number of countries. In Germany, screening colonoscopy at …

Introduction: Screening is an effective means for colorectal cancer prevention and early
detection. Family history is strongly associated with colorectal cancer risk. We describe the …